|
|
| IPO Open | Sep 9, 2008 |
| IPO Close | Sep 12, 2008 |
| IPO Price | ₹16 |
| Face Value | ₹10 |
| IPO Size | ₹24.64 Cr |
| Listing At | BSE |
| Lot Size |
Oct 5, 2022 8:10:00 PM
Third Harmonic Bio’s stock market debut was the only biotech IPO that crossed the $100 million threshold in the third quarter as the slowdown in IPO activity showed little sign of changing. Small ...
Publish by : MedCity NewsSep 18, 2022 5:30:00 PM
recent acquisitions of biotechs, and strong clinical-trial data from several drugmakers are whetting investor appetite, which will likely lead to more IPOs, investors and analysts say.
Publish by : Wall Street JournalSep 9, 2022 3:30:00 AM
and that biotech IPOs have done exceptionally well of late. “The phone is ringing now,” Blair says, with LPs checking references on venture capitalists. He predicts that some of the VC firms ...
Publish by : XconomySep 15, 2022 3:30:00 AM
We also discuss the White House’s investment in biotech, a bellwether IPO, and the latest twist in the Merck-Seagen saga. Biotech Startups and Venture Capital Reporter Allison is a biotech ...
Publish by : STATSep 16, 2022 1:37:00 PM
Third Harmonic's ticker symbol is "THRD." Morgan Stanley, Jefferies and Cowen backed the listing. The company is only the sixth Massachusetts-based biotech to hold an IPO this year. The last IPO ...
Publish by : The Business JournalsSep 16, 2022 12:59:00 AM
Wednesday evening, the biotech offered 10.9 million shares priced at $17 each, which was the midpoint of its targeted price range. When the company set financial terms for the IPO last week ...
Publish by : MedCity NewsMay 19, 2020 7:34:00 PM
Legend Biotech is spinning out from parent firm GenScript Biotech to pursue treatments in CAR T cell therapies for multiple myeloma. Legend Biotech is spinning out from parent firm GenScript ...
Publish by : TheStreet.comAug 25, 2022 3:49:00 AM
Natalie Holles is the CEO of Third Harmonic Bio. A Cambridge biotech startup may break the monthslong lull in the local IPO market, just six months after its public launch. Third Harmonic Bio ...
Publish by : The Business JournalsJul 27, 2022 7:30:00 PM
MAIA Biotechnology, Inc. (NASDAQ:MAIA) IPO will take place July, 28 on the NASDAQ exchange under the ticker MAIA. The company is offering shares at an expected price between $5.00 and $7.00 per ...
Publish by : MSNSep 28, 2022 3:30:00 AM
Windlas Biotech shares were trading at a premium of Rs 110-130 in the grey market, translating to 23.9-28.3 percent premium over the issue price of Rs 460, the IPO Watch and IPO Central data shows.
Publish by : moneycontrol.comSep 9, 2022 3:30:00 AM
But this is shaping up to be the year the storyline changes, thanks to the ripple effect from the biotech IPO class of 2013. It’s still too early to say that biotech VCs have climbed all the way ...
Publish by : XconomyChemcel Biotech Limited IPO stock listed today at a huge discount of around 68%. An Agro Chemicals manufacturer's fixed price IPO was priced at Rs 16 and closed for subscription on September 12.
Chemcel stock opened at its issue price of Rs 16 and then keeps falling all day. At one point the stock went down to its day low of Rs 4.75. Later the stock recovered a little and finally closed at Rs 5.25, around -68% from its issue price.
Most of the experts told investors not to apply in this IPO. The grey market premiums were running at Rs 2 to Rs 3 just before its listing.
Chemcel Biotech IPO Listing Date & Info:
IPO Listing Date: Monday, October 13, 2008
BSE Script Code: 533026
Listing in: 'B' Group of Securities
ISIN: INE213J01012
Issue Price: Rs 16/- Per Equity Share
Face Value: Rs 10/- Per Equity Share
IPO Allotment Status is now available online for Chemcel Biotech Limited IPO.
Chemcel Biotech IPO was open on September 09, 2008 and closed on September 12, 20.
The Chemcel Biotech IPO is proposed to open on Sep 9, 2008. The IPO application ends on Sep 12, 2008.
Retail investors can apply in the retail or non-institutional investor category from Sep 9, 2008 to Sep 12, 2008. The Chemcel Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Chemcel Biotech IPO will open for subscription on Sep 9, 2008. The public issue will close on Sep 12, 2008.
Useful Articles
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
